ArticleEClinicalMedicine2026

Risk of adverse pregnancy outcomes following inadvertent exposure to ivermectin during the periconception period: findings from two cluster-randomized trials in Mozambique and Kenya.

Patricia Nicolas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.